This delivers concentrated peptide to surrounding tissue while avoiding further trauma to the healing area
MOTS-c Strength: 10 mg Mitochondrial-derived peptide A performance and energy-oriented peptide option frequently associated with metabolic resilience support
Individuals under 18 years of age Pregnant or breastfeeding women Individuals with medical conditions (unless approved by a healthcare professional) Anyone advised against metabolic-active compounds Generally well tolerated, but may include: Mild skin irritation Headache Nausea Changes in energy levels Users may experience improved metabolism, increased energy, and gradual improvements in body composition with consistent use
While physicians may not be familiar with research-stage peptides, providing information about what you are taking allows them to monitor for potential interactions or contraindications
This aligns with user reports of stabilized improvements by month 4
Lenti MV, Rugge M, Lahner E et al (2020) Autoimmune gastritis